Last reviewed · How we verify

NCT05533684

A Single Preoperative Dose of Gabapentin to Decreases Postoperative Pain in Ambulatory Anal Surgeries

Completed EARLY_PHASE1 Last updated 16 March 2023
What this trial tests

EARLY_PHASE1 trial testing Gabapentin in Pain, Postoperative in 50 participants. Completed in 31 December 2022.

Timeline
1 September 2022
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorMinia University
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment50
Start date1 September 2022
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 18 to 65, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single dose 600 mg gabapentin will be given preoperatively in anal surgeries

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Gabapentin

Trials testing the same drug.

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05533684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing